SWK Holdings (SWK Holdings) ROCE % : 2.24% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is SWK Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SWK Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 2.24%.

SWK Holdings ROCE % Historical Data

The historical data trend for SWK Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SWK Holdings ROCE % Chart

SWK Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

7.40

1.62

12.46

3.44

5.28

SWK Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-5.90	6.47	7.99	5.90	2.24

SWK Holdings ROCE % Calculation

SWK Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	16.462	/	( ( (299.621 - 6.347)	+	(334.254 - 3.944) )	/ 2 )
	=	16.462	/	( (293.274	+	330.31)	/ 2 )
	=	16.462	/	311.792
	=	5.28 %

SWK Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	6.956	/	( ( (315.845 - 24.768)	+	(334.254 - 3.944) )	/ 2 )
	=	6.956	/	( ( 291.077	+	330.31 )	/ 2 )
	=	6.956	/	310.6935
	=	2.24 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

SWK Holdings (NAS:SWKH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SWK Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of SWK Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

SWK Holdings (SWK Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » SWK Holdings Corp (NAS:SWKH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

14755 Preston Road, Suite 105, Dallas, TX, USA, 75254

Website

https://www.swkhold.com

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Executives

Jerry Albright	director	C/O SWK HOLDINGS CORP, 14755 PRESTON ROAD, SUITE 105, DALLAS TX 75254
Yvette M Heinrichson	officer: Chief Financial Officer	14755 PRESTON ROAD, SUITE 105, DALLAS TX 75254
Staggs Joe David Jr	officer: PRESIDENT	14755 PRESTON ROAD, SUITE 105, DALLAS TX 75254
Marcus Edward Pennington	director	2100 MCKINNEY AVENUE, SUITE 1800, DALLAS TX 75201
Wendy F Dicicco	director
Robert K. Hatcher	director	2929 ALLEN PARKWAY, SUITE 3000, HOUSTON TX 77019
Laurie L. Dotter	director	3615 WEST LAWTHER DRIVE, DALLAS TX 75214
Black Winston L Iii	officer: Chief Executive Officer	14755 PRESTON ROAD, SUITE 105, DALLAS TX 75254
Fletcher Aaron G.l.	director	40 GUEST STREET, BOSTON MA 02135
Carlson Capital L P	director, 10 percent owner, other: See Remarks	2100 MCKINNEY AVE, STE 1900, DALLAS TX 75201
Dana Blair Baker	director	200 CRESCENT COURT, SUITE 1450, DALLAS TX 75201
James Brett Pope	director, officer: CEO	4020 SAHARA CT., CARROLLTON TX 75010
Edward B Stead	director	14755 PRESTON ROAD, SUITE 105, DALLAS TX 75254
Christopher W Haga	director	PO BOX 10809, DAYTONA BEACH FL 32120
Black Diamond Offshore Ltd.	director, 10 percent owner, other: See Remarks	CITCO FUND SERVICES, 89 NEXUS WAY, P.O. BOX 31106, GRAND CAYMAN E9 KY1-1205